PVpharm becomes member of ASEBIO
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
Information about PVpharm
Christmas 2021: the most unique moments
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
Christmas 2021 arrives at PVpharm
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
PVpharm invited to ICARO Awards 2021 from University of Almería
PVpharm has been invited to the ICARO Awards from the University of Almería (UAL) one more year. This act recognises the importance of the alliance between PVpharm and the highest educational institution in Almería, the University.
New Clinical Trials Information System (CTIS): key areas
The European Commission has informed that the entry into application of the Clinical Trials Regulation (CTR) and hence the go-live date for the CTIS will be on 31 January 2022.
PVpharm’s offsite meeting 2021: a memorable event (VIDEO)
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
PVpharm contributes to a recent article about the Covid vaccine
"Pharmacovigilance in times of COVID-19 vaccines", is an article published in the Spanish journal Pharmatech and in which José Alberto Ayala Ortiz has been co-author. The world is facing the unprecedented challenge of the SARS-CoV-2 pandemic. The hope for a normal life relied on vaccines is compromised by messages that question them. For this reason, pharmacovigilance activities carried out by authorities, pharmaceutical laboratories, health professionals and patients are essential to assess information and not to rely on "fake news". In this regard, the article aims to highlight the role of pharmacovigilance. It is important that society, in addition to being…
José Ortiz to participate in the AEFI Symposium 2021
We are happy to announce that José Ortiz, PVpharm's CEO will be participating in one session of the 2021 Pharmacovigilance symposium organized by AEFI. During the session, José will be talking about outsourcing of pharmacovigilance activities. Please take a look to the program at this link: https://www.aefi2021.com/
PVpharm provides support to the UCLouvain for COVID-19 phase II study project
We are happy to announce that PVpharm has been selected to provide safety support for a research project coordinated by the Catholic University of Louvain (UCLouvain) for a COVID-19 Phase II study. PVpharm will be supporting the clinical safety function with pharmacovigilance, report submission, safety report writing, Eudravigilance, CTIS and other PV and administrative related activities. PVpharm is providing support to Sponsors of clinical trials in the EU, please read more about our Pharmacovigilance services at https://pvpharm.com/pharmacovigilance/ Please contact us with any question https://pvpharm.com/contact/
PVpharm and Azierta agrees on a strategic alliance in Pharmacovigilance
PVpharm and Azierta agrees on a strategic alliance in the field of Pharmacovigilance. This alliance will make it possible to jointly design and commercialize advanced pharmacovigilance services both for the Spanish market and internationally. The alliance signed places both companies in a position of reference in the health consulting sector in the field of pharmacovigilance in Spain, currently providing its services to more than 2,000 clients that represent 80% of the pharmaceutical industry and a share close to 25 % of the market for pharmacovigilance services. PVpharm is supporting and helping organizations to improve their quality processes in Pharmacovigilance. Please…